Related Experiment Video
Updated: Aug 8, 2026

06:34
Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
Published on: October 28, 2020
China-calibration-ready echocardiographic feature modeling for LVEF-derived dysfunction classification: a
Mingzhu Yang1, Ying Qian1, Yuhui Zhang1
1Department of Ultrasound, The People's Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, Danyang, Jiangsu, China.
Frontiers in Medicine
|August 7, 2026
Summary
This study developed a machine-learning pipeline using echocardiography to identify left ventricular dysfunction. The model achieved high accuracy but requires further validation for clinical use in predicting cardiotoxicity.
Area of Science:
- Cardiology
- Medical Imaging
- Machine Learning
Background:
- Anthracycline chemotherapy can cause cardiotoxicity, impacting right ventricular function.
- Accurate prediction of cardiotoxicity is crucial for patient management.
- Echocardiography is a key imaging modality for assessing cardiac function.
Purpose of the Study:
- To present a reproducible echocardiographic feature-engineering and machine-learning pipeline.
- To classify a surrogate label for left ventricular dysfunction derived from left ventricular ejection fraction (LVEF).
- To serve as a methodological proof-of-concept for future clinical applications.
Main Methods:
- Utilized a dataset of 1,000 two-dimensional echocardiographic tracings from public databases.
- Engineered twelve geometric and morphometric features, including left ventricular trace-area and bounding-box area changes.
- Trained five classifiers, including logistic regression, using stratified splits and cross-validation.
Main Results:
- Logistic regression achieved a high ROC-AUC of 0.996 and F1 score of 0.966.
- Performance metrics reflect feature-label coupling, not independent clinical prediction.
- Left ventricular trace-area change mediated the association between bounding-box area change and dysfunction.
Conclusions:
- The study provides a transparent, reusable analytical scaffold for future research.
- The pipeline is a proof-of-concept, not a clinically validated predictive model.
- Future work should incorporate prospective data with true right ventricular outcomes for cardiotoxicity prediction.